NKGen Biotech, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NKGen Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2023.
  • NKGen Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.1M, a 105% decline year-over-year.
  • NKGen Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$88.3M, a 92.3% decline year-over-year.
  • NKGen Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$83M, a 210% decline from 2022.
  • NKGen Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.8M, a 2601% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$83M -$56.2M -210% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$26.8M -$25.8M -2601% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$991K Jan 28, 2021 Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.